Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$0.96 - $1.78 $7,083 - $13,134
-7,379 Reduced 6.96%
98,710 $157,000
Q1 2023

May 12, 2023

SELL
$0.56 - $0.89 $85,014 - $135,111
-151,811 Reduced 58.86%
106,089 $94,000
Q4 2022

Feb 13, 2023

BUY
$0.57 - $0.95 $108,116 - $180,194
189,678 Added 278.03%
257,900 $152,000
Q3 2022

Nov 14, 2022

BUY
$0.88 - $1.91 $19,780 - $42,932
22,478 Added 49.14%
68,222 $63,000
Q2 2022

Aug 12, 2022

SELL
$1.06 - $1.82 $22,898 - $39,315
-21,602 Reduced 32.08%
45,744 $59,000
Q1 2022

May 13, 2022

BUY
$1.46 - $2.18 $77,739 - $116,076
53,246 Added 377.63%
67,346 $115,000
Q4 2021

Feb 11, 2022

SELL
$1.98 - $3.06 $5,742 - $8,874
-2,900 Reduced 17.06%
14,100 $29,000
Q3 2021

Nov 12, 2021

SELL
$2.65 - $3.35 $161,141 - $203,706
-60,808 Reduced 78.15%
17,000 $47,000
Q2 2021

Aug 13, 2021

SELL
$2.63 - $4.88 $1.12 Million - $2.09 Million
-427,313 Reduced 84.6%
77,808 $219,000
Q1 2021

May 13, 2021

BUY
$2.38 - $4.0 $566,756 - $952,532
238,133 Added 89.19%
505,121 $1.41 Million
Q4 2020

Feb 10, 2021

SELL
$1.47 - $3.62 $420 - $1,035
-286 Reduced 0.11%
266,988 $673,000
Q3 2020

Nov 13, 2020

BUY
$1.56 - $2.37 $171,481 - $260,519
109,924 Added 69.86%
267,274 $438,000
Q2 2020

Aug 13, 2020

BUY
$1.23 - $2.39 $193,540 - $376,066
157,350 New
157,350 $269,000

Others Institutions Holding BLRX

About BioLineRx Ltd.


  • Ticker BLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,524,500
  • Market Cap $12.3M
  • Description
  • BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...
More about BLRX
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.